Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
That's what I hoped for and I think needed to happen. I have been critical of AS as CEO as we moved through the gears and think this was needed but wish him all the best in the future, the company would not have got to where it is now without him.
"Who says they are mistakes"
Jesus I am in a comedy club. here are a few more for you Ice. "Dont worry about funding", "Shareholder Value", "No Placing" "Raise unlikely at under £1" "Start of the value curve" "Start of commercialisation" "Lots want it" "Prefer non dilutive methods" "We dont know how to use a calulator but please take us seriously" "I have a lot riding on avacta as I have a lot of options (Plus my small 400k salary)"
As always no doubt in the science or the fact that AS is a great scientist regardless of what I think of him as a CEO its the reason I have not sold but the management team seems to be serverely lacking in my opinion but once again lets pretend everything is A OK and there does not need to be any accountability. Id like to start with why the feck our CFO either cant use a calculator or they are so disorganisaed they dont double check a RNS, pretty much everyone spotted that mistake as soon as they read it how did a company valued at 150m not? Rookie mistake, who is to say the next one is not the CFO signing away the company for £1.00 a share instead of £10.00 because he didnt count his zeros)
I would love AS and the team to prove me wrong and see true value for the company and make me eat my words as it would make me a very rich fella but I just dont see it under this leadership after 4 years and a lot of fluff.
I sat looking at that for 10 minutes trying to work out if I was the idiot but seems not, this is the guy that is paid a lot of money to do the maths and we wonder why we are in the $hitter SP wise. Am I missing something with the numbers still convinced I am been daft as using a calulator is not that hard?
What i found:
When a U.S. investor buys shares in a UK company listed on the AIM, especially during a placing, they might encounter what's known as a "40-day news blackout" or more formally, a "quiet period." This isn't a standard term you'll find in UK financial regulation; instead, it's more akin to U.S. securities law, particularly when dealing with the involvement of U.S. investors or securities being offered to U.S. persons.
So, why would this U.S. concept affect a UK company? Well, it's all about the global nature of investments. If a UK company is raising capital and its shares are being offered to U.S. investors, it might voluntarily adhere to similar standards to those required in the U.S. to ensure compliance and to make the offering more attractive to U.S. investors. This 40-day period is akin to a self-imposed "quiet period" by the company to align with what U.S. investors might expect based on their domestic regulations.
In essence, during this 40-day news blackout, the company would refrain from releasing any promotional material or major news about the company that could influence the stock price, except for legally required disclosures. This is to ensure fairness and transparency during the post-placement period.
"won’t be saying that once the first deal is signed and delivered" 100% agree spot on he wont be saying that when as signs the first deal as we will all be dead by the time AL whips out his bloody parker pen ffs.
There wont be one anytime soon Ice anyway as AL is only signing deals if its a decent size one for a gazillion trillion it seems.
Just give it up PL you are not allowed to say anything negative about AS or his business accumen already had my warning from LSE.......
Everything is rosey the fact the share price is 52p is no problem at all, AS is a genius, the DX purchase was genius, I wish he was my dad, all hail Al.
Https://www.fidelity.co.uk/factsheet-data/factsheet/GB00BYYW9G87-avacta-group-plc/profile
Dont be lazy maybe do a better job of looking into my posting history I have never said the science is not great. Thats not the issue
Last year you said ‘Still think avacta will go from strength to strength over the next 6-12’ and that this would be a £1bn company in 2024.
Thats when AS was telling us not to worry about funding, spouting maximising shareholder value, talking about value curves and commercialisation. You make judgements given the information thats provided. Maybe still will be a billion company by dec 2024 if the right decisions are made then im still right eh?
stop been a sheep
I take everything that the pump squad on twitter say with a pinch of salt. Having said that what I have just seen posted by McNulty could have been pulled straight out of my head. Although I was thinking slightly lower than 200p/s
"The fact that the share price hasn't budged after the sublime #AVA6000 data presented yesterday, will have licensees at advanced stage of due diligence thinking, "Why pay all that cash upfront for rights to only a single indication for a single pre | CISION drug, when we can just acquire the entire company for 200p/s?"
Avacta is now a sitting duck, I have absolutely no doubt about it.
And in advance of people responding, "Not a chance that a 200p offer would be accepted! " - I would suggest that there are very many holders who would bite an offeror's hand off, at such a price, given the plethora of commercial failings by Avacta's management in recent times, and the resultant overseeing of substantial destruction of shareholder value."
Full tweet for clarity as I only pasted part of it: https://twitter.com/MylesMcNulty/status/1778036208993501340
And your confusing your "hopes and dreams" for the company with the facts that we can all see at this moment in time. I feel like Avacta is your flat earth Ice and regardless of facts or evidence to the contrary the earth is still flat.
You do you and I will do me ;-)
Jesus here we are sat at under the placing price and people like you are still talking absolute$hite. I have seen so many of the rampers and BS merchants gradually creep back in since the placing with the be patient, will come good, wait for the conference, news blackout, rehashed old info blah blah blah etc etc etc.
Personally I now feel like the science is in the wrong hands (I still think the science is strong) Avacta are not the company to take this forward for the benefit of cancer suffers unless it appears we are prepared to wait 50 years for them to get their act together (dont pretend timelines have not slipped again and again and again). They are commercially inept as far as I can see on evidence so far and have the communication skills of a bag of crisps, this opinion is formed on the basis of all the tosh we have been told about commercialisation, everyone wants it, no placing, non dilutive funding, share holder value (I could go on)
What am I hoping for now? Well either changes at board level to actually move the company forward which is not going to happen, I foresee much of the same if the board stays as it is. We will all be back in 6-12 months angry that they shafted us... AGAIN. My second preference is just sell the company for £1.11 ( My average is £1.10.) so I get my money back and put the science in the hands of someone who will take it forward at a reasonable pace. (currently at 49p getting my money back seems as likely as AS stepping aside )
Rampers can come on with their bull$hit I dont care what you have to say I really dont save your breath (I read the same RNS as you believe it or not, I am just not as blinkered). The share price is under the placing ffs stop defending the incompetence of the board and the "ah well that happened lets move on" attitude and expect some accountability for the lies and waffle we have been fed over the past 4 years.
The science seems good and I would love to be wrong but I am pretty sure now its in the wrong hands.